Is Increased Screening and Early Antiretroviral Treatment for HIV-1 Worth the Investment?

An Analysis of the Public Health and Economic Impact of Improvement in the UK

AJ Brogan; SE Talbird; AE Davis; L Wild; D Flanagan

Disclosures

HIV Medicine. 2019;20(10):668-680. 

In This Article

Conclusions

Our analysis demonstrates that increased HIV screening followed by early treatment initiation may be a cost-effective strategy to further reduce HIV transmission and improve health for MSM, heterosexuals, and PWID in the UK.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....